Novavax reported $792K in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Adma Biologics ADMA:US USD 20K 0
Agenus AGEN:US USD 2.95M 120K
AstraZeneca AZN:LN USD 387M 0
Astrazeneca AZN:US USD 387M 0
GlaxoSmithKline GSK:LN GBP 1.35B 0
Mannkind MNKD:US USD 2.63M 59K
Minerva Neurosciences NERV:US USD 1000 0
Moderna Inc MRNA:US USD 38.7K 500
Novartis NVS:US USD 890M 0
Novavax NVAX:US USD 792K 4K
Pain Therapeutics PTIE:US USD 40K 0
Peregrine Pharmaceuticals PPHM:US USD 62K 0
Sarepta Therapeutics SRPT:US USD 9K 0
Tg Therapeutics TGTX:US USD 145K 0